Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Moodys
Mallinckrodt
Colorcon
AstraZeneca

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Litigation Details for Sciele Pharma Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2007)

See Plans and Pricing

« Back to Dashboard

Sciele Pharma Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2007)

Docket   Start Trial Date Filed 2007-12-14
Court District Court, D. Delaware Date Terminated 2008-06-09
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand Both Referred To Leonard Philip Stark
Parties MYLAN LABORATORIES INC.; MYLAN PHARMACEUTICALS INC.; SCIELE PHARMA CAYMAN LTD.; SCIELE PHARMA INC.
Patents 4,264,611; 4,803,081; 4,892,741
Attorneys Deanna J. Reichel; Mary Matterer; Susan Morrison Coletti; William J. Marsden , Jr.
Link to Docket External link to docket
Small Molecule Drugs cited in Sciele Pharma Inc. v. Mylan Pharmaceuticals Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Sciele Pharma Inc. v. Mylan Pharmaceuticals Inc. (D. Del. 2007)

Date Filed Document No. Description Snippet Link To Document
2007-12-14 1 Complaint for infringement of United States Patent No. 4,892,741 (“the ’74l patent”) under 35 U.S.C. § 27l(e)(2). …StateS Pat€llt [19] [11] Patent Number: 4,892,741 Ohm et al. [45] Date of Patent: Jan. 9, 1990 [54] PRESS…Filed 12/14/2007 Page 2 Of 10 U.S. Patent Jan..9, 1990 4,892-,741 y % 1001 Nnr d" /__““"` “…00818-G|\/|S-LPS Document 1-2 Filed 12/14/2007 4,892,741 1 PRESS COATED DHP TABLETS Active compounds …00818-G|\/|S-LPS Document 1-2 Filed 12/14/2007 4,892,741 . 5 different, but the specification refers only External link to document
2007-12-18 10 Declaration true and accurate copy of U.S. Patent No. 4,892,741 (the ‘74l patent”) is attached hereto as Exhibit…rates according to this US patent specification may be Page 5 of 72 4 ,892,741 t 5 _ different, but the…-G|\/|S-LPS Document 10-2 Filed 12/18/2007 4, 892, 741 1 PRESS CoATED DHP TABLETS Active compounds…00818-G|\/|S-LPS Document 10-2 Filed 12/18/2007 4,892,741 3 R2 represents a nitro group or the radical…00818-G|\/|S-LPS Document 10-2 Filed 12/18/2007 4,892,741 7 50 g of crystalline nifedipine (mean particle External link to document
2008-01-28 15 Answer to Counterclaim Office (“ PTO” ) issued U.S. Patent No. 4,892,741 (“ the ’741 patent” ), entitled “ Press Coated DHP… Patent-in-Suit 9. On or about January 9, 1990, the U.S. Patent and Trademark… 5. This Counterclaim arises under the Patent Laws of the United States, 35 U.S.C. § 1 et seq…GMS (D.Del.), alleging infringement of the ’ 741 patent under 35 U.S.C. § 271(e)(2)(A) with respect to…this District alleging infringement of the ’ 741 patent under 35 U.S.C. § 271(e)(2)(A) with respect to External link to document
2008-02-04 19 Redacted Document the necessary rights in U.S. Patent No. 4,892,741 ("the '741 Patent") to sue Mylan in Sciele…Substantial Rights" in the '741 Patent. The Patent Act provides that a "patentee"…enforcement of the patent for practical purposes; (2) the right to grant sublicenses to the patent; (3) the right…and sell the patented invention; and (4) title to and the obligation to maintain the patent. See Propat…the ... patent is so sweeping that it has become in economic reality the assignee of the patent") External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
AstraZeneca
Express Scripts
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.